IRIS
PUGLIESE, Alessia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 995
EU - Europa 943
AS - Asia 634
SA - Sud America 138
Continente sconosciuto - Info sul continente non disponibili 62
AF - Africa 15
Totale 2.787
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 937
RU - Federazione Russa 575
SG - Singapore 256
CN - Cina 162
IT - Italia 132
BR - Brasile 105
HK - Hong Kong 63
IE - Irlanda 47
VN - Vietnam 44
SE - Svezia 35
DE - Germania 32
CA - Canada 29
IN - India 24
FI - Finlandia 23
FR - Francia 22
GB - Regno Unito 20
BD - Bangladesh 16
AR - Argentina 15
NL - Olanda 14
PL - Polonia 14
AT - Austria 12
JP - Giappone 12
TR - Turchia 9
ID - Indonesia 7
IQ - Iraq 7
TH - Thailandia 7
MX - Messico 6
ZA - Sudafrica 6
GT - Guatemala 5
JM - Giamaica 5
VE - Venezuela 5
ES - Italia 4
SV - El Salvador 4
AZ - Azerbaigian 3
CO - Colombia 3
EC - Ecuador 3
GP - Guadalupe 3
HN - Honduras 3
IL - Israele 3
PE - Perù 3
PH - Filippine 3
PK - Pakistan 3
PY - Paraguay 3
TN - Tunisia 3
CI - Costa d'Avorio 2
EE - Estonia 2
KR - Corea 2
KZ - Kazakistan 2
LT - Lituania 2
MA - Marocco 2
MY - Malesia 2
SA - Arabia Saudita 2
UA - Ucraina 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
BE - Belgio 1
BG - Bulgaria 1
BO - Bolivia 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GR - Grecia 1
HT - Haiti 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
NP - Nepal 1
OM - Oman 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
Totale 2.726
Salva come PNG Salva come JPEG
Città #
Ashburn 155
Singapore 152
Moscow 145
San Jose 80
Dallas 75
Hong Kong 63
Dublin 47
Beijing 39
Council Bluffs 33
Los Angeles 31
Messina 28
Chandler 22
The Dalles 21
Ho Chi Minh City 18
New York 17
Nyköping 16
Munich 15
Orem 15
North Bergen 14
Milan 13
Atlanta 12
Santa Clara 12
São Paulo 12
Guangzhou 11
Tianjin 11
Turku 10
Warsaw 10
Amsterdam 9
Frankfurt am Main 9
Montreal 9
Palermo 9
Rome 9
Chennai 8
Lauterbourg 8
Phoenix 8
Brooklyn 7
Buffalo 7
Denver 7
Hanoi 7
Mumbai 7
Shenzhen 7
Tokyo 7
Toronto 7
Columbus 6
Medford 6
Nuremberg 6
Princeton 6
Redondo Beach 6
Stockholm 6
Wilmington 6
Bağlar 5
Catania 5
Lappeenranta 5
Shanghai 5
Bangkok 4
Boston 4
Chicago 4
Des Moines 4
Espoo 4
Manchester 4
Qingdao 4
Rio de Janeiro 4
St Petersburg 4
Baku 3
Campinas 3
Castellammare di Stabia 3
Falls Church 3
Francofonte 3
Guatemala City 3
Helsinki 3
Hyderabad 3
Johannesburg 3
Kingston 3
Lima 3
San Francisco 3
Seattle 3
Suffern 3
Vienna 3
Abidjan 2
Baghdad 2
Baoding 2
Birmingham 2
Buenos Aires 2
Cachoeiro de Itapemirim 2
Calgary 2
Cape Coral 2
Caxias do Sul 2
Changsha 2
Chesapeake 2
Córdoba 2
Dhaka 2
Florence 2
Fort Wayne 2
Guayaquil 2
Houston 2
Ijuí 2
Istanbul 2
Jakarta 2
Jinan 2
Kansas City 2
Totale 1.389
Salva come PNG Salva come JPEG
Nome #
Immune checkpoint inhibitors and neurotoxicity: a focus on diagnosis and management for a multidisciplinary approach 250
A new phenotype of muscle glycogen synthase deficiency (GSD0B) characterized by an adult onset myopathy without cardiomyopathy 195
NfL as a biomarker in ATTRv amyloidosis: potential and limitations 192
Endocrine myopathies: Clinical and histopathological features of the major forms 155
Efficacy and Safety of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease After 97 Weeks: A Phase 3 Randomized Clinical Trial 155
Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial 154
STIG study: real-world data of long-term outcomes of adults with Pompe disease under enzyme replacement therapy with alglucosidase alfa 144
A very late onset AChR and MuSK double positive myasthenia gravis: a case description and literature review 143
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): Position paper on diagnosis, prognosis, and treatment by the MNGIE International Network 141
Integrating D4Z4 methylation analysis into clinical practice: improvement of FSHD molecular diagnosis through distinct thresholds for 4qA/4qA and 4qA/4qB patients 130
Methotrexate as a steroid-sparing agent in myasthenia gravis: A preliminary retrospective study 127
Digital health and clinical patient management system (CPMS) platform utility for data sharing of neuromuscular patients: the Italian EURO-NMD experience 116
Molecular Genetics Overview of Primary Mitochondrial Myopathies 115
Clinical and therapeutic clues from a long-term follow-up: a single center experience on a large LOPD population 110
Management of presymptomatic juvenile patients with late-onset Pompe disease (LOPD) 106
Focal myositis: a literature review of clinical and immunopathological aspects 102
Clinical, Histopathologic, and Genetic Features of Patients With Myofibrillar and Distal Myopathies 100
Long term clinical follow-up and natural history in a cohort of Italian patients with GNE myopathy: the experience of a single centre 84
Presynaptic Congenital Myasthenic Syndromes: Understanding Clinical Phenotypes through In vivo Models 70
Advancing the Understanding of Vesicle-Associated Membrane Protein 1-Related Congenital Myasthenic Syndrome: Phenotypic Insights, Favorable Response to 3,4-Diaminopyridine, and Clinical Characterization of Five New Cases 63
Mutations in PTPN11 could lead to a congenital myasthenic syndrome phenotype: a Noonan syndrome case series 61
Liver transplantation in mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical long-term follow-up and pathogenic implications 58
Myopathy and ataxia related to impaired mitochondrial function in mevalonate kinase deficiency 16
Totale 2.787
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.374
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.374
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202243 0 0 0 0 2 3 6 2 2 10 2 16
2022/2023120 7 7 5 3 3 14 0 9 62 1 7 2
2023/202450 3 4 1 6 5 5 0 9 1 5 5 6
2024/2025444 25 1 12 33 28 6 51 35 85 43 45 80
2025/20261.683 161 76 116 128 160 281 160 211 203 113 34 40
2026/2027439 57 171 49 150 12 0 0 0 0 0 0 0
Totale 2.787